{"gao_id": "GAO-13-702", "published": "2013-07-31T12:00:00Z", "released": "2013-07-31T08:00:00Z", "summary": "", "title": "Drug Compounding: Clear Authority and More Reliable Data Needed to Strengthen FDA Oversight", "topics": ["Manufacturing industry", "Government agency oversight", "Law courts", "Drug formularies", "Drug approvals", "Pharmaceutical industry", "Authority", "Databases", "Drug trafficking", "Data collection", "Product recalls", "Health Care", "Contamination", "Prescription drugs", "Inspection"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-13-702", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-13-702-highlights.pdf"}, {"title": "Full Report (50 pages)", "url": "https://www.gao.gov/assets/gao-13-702.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/660/656432.txt"}]}